Williams D, Kelly A, Feely J
Departments of Pharmacology and Therapeutics and Community Health and General Practice, Trinity College, Dublin 2, Ireland.
Br J Clin Pharmacol. 2000 Apr;49(4):369-72. doi: 10.1046/j.1365-2125.2000.00177.x.
To develop an index of quality prescribing in general practice by investigating the incidence of potential drug interactions when medicines were coprescribed within the State supported General Medical Services (GMS) in Ireland.
We determined an odds ratio (OR), as a measure of the relative risk of being exposed to a potential interaction, comparing the use of the H2-receptor antagonist, cimetidine, with that of the noninteracting agents ranitidine, famotidine and nizatidine in users and nonusers of warfarin, phenytoin and theophylline.
In 86 510 prescriptions for the H2-receptor antagonists potentially interacting drugs were dispensed to 8188 (9%) patients in the Eastern Health Board Region of the GMS. We found that prescribers were significantly less likely to use cimetidine (OR = 0.20,95% CI 0. 17-0.21, P < 0.001) in those patients who were coprescribed warfarin, suggesting good prescribing practice within the GMS. Similarly there was preferential use of the noninteracting H2-receptor antagonists in patients receiving phenytoin or theophylline and the extent of this selective prescribing was in keeping with the rank order of severity of interaction with these drugs. This novel pharmacological index may be a sensitive marker of good prescribing practice.
通过调查爱尔兰国家支持的全科医疗服务(GMS)中联合开具药物时潜在药物相互作用的发生率,制定一个全科医疗质量处方指数。
我们确定了比值比(OR),作为暴露于潜在相互作用相对风险的衡量指标,比较了使用H2受体拮抗剂西咪替丁与使用无相互作用药物雷尼替丁、法莫替丁和尼扎替丁的华法林、苯妥英和茶碱使用者及非使用者。
在GMS东部卫生委员会地区,86510张H2受体拮抗剂处方中,有8188名(9%)患者配到了潜在相互作用药物。我们发现,在联合开具华法林的患者中,开具西咪替丁的处方者明显较少(OR = 0.20,95%CI 0.17 - 0.21,P < 0.001),这表明GMS内的处方行为良好。同样,在接受苯妥英或茶碱的患者中,优先使用无相互作用的H2受体拮抗剂,这种选择性处方的程度与这些药物相互作用严重程度的排序一致。这个新的药理学指数可能是良好处方行为的一个敏感指标。